An Open-label, Multi-center, Randomized Study Comparing the Effects of Oral Hypoglycemic Agents on Viral Kinetics of Chronic Hepatitis C Patients Receiving Pegylated Interferon Alfa 2b Plus Ribavirin.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2012
At a glance
- Drugs Acarbose; Metformin; Peginterferon alfa-2b; Pioglitazone; Ribavirin
- Indications Insulin resistance
- Focus Pharmacodynamics
- 26 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Dec 2009 New trial record